Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex

This publication has 28 references indexed in Scilit:

• Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes
  Journal of Neuroimmunology, 1993
• Distributions of neuropeptide Y, vasoactive intestinal peptide and somatostatin in populations of postganglionic neurons innervating the rat kidney, spleen and intestine
  Neuroscience, 1992
• Inhibition of mouse T‐cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL‐2 production and cAMP synthesis
  Journal of Neuroscience Research, 1991
• Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration
  Acta Physiologica Scandinavica, 1991
• Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus
  Brain, Behavior, and Immunity, 1990
• Interleukin 2, 4 and 5 are sequentially produced in mitogen‐stimulated murine spleen cell cultures
  European Journal of Immunology, 1990
• Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation?
  Neuroscience Letters, 1988
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
  The Journal of Experimental Medicine, 1987
• Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells
  Peptides, 1986
• Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts
  Regulatory Peptides, 1983